Multiple sclerosis strikes women roughly two to three times more often than men, and that gap has been widening over the past several decades. The reasons are not reducible to a single gene or a single hormone. Instead, a web of interacting factors, from the X chromosome and estrogen signaling to Epstein-Barr virus exposure and childhood body weight, converges to make the female immune system more likely to turn against its own central nervous system. Understanding these risk factors individually is useful, but what makes MS in women so difficult to pin down is how many of them amplify each other.
How Sex Hormones Shape the Immune Landscape
Estrogen has a paradoxical relationship with MS. On one hand, estrogen is broadly immunostimulatory: it boosts the number and activity of certain T cells and antibody-producing B cells, which may help explain why women mount stronger immune responses to infections but also face a higher burden of autoimmune disease. On the other hand, high levels of estrogen, like those seen during pregnancy, appear to shift the immune system toward a more tolerant, anti-inflammatory state. This duality plays out through two different estrogen receptors. In animal models of MS, activating one receptor (ERα) reduces inflammation in the peripheral immune system, while activating the other (ERβ) directly protects myelin and nerve fibers in the brain and spinal cord without dampening peripheral inflammation.1PubMed Central. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice Both pathways have therapeutic potential.2PubMed Central. Estrogen treatment in multiple sclerosis
Women also show more robust myelin-targeting T-helper-1 immunity than men, both in MS itself and in experimental models of the disease. This sex difference is driven not just by hormones acting on T cells directly, but also by how hormones influence the cells that present fragments of myelin to the immune system, essentially setting the stage for an autoimmune attack.3PubMed. Immune Cell Contributors to the Female Sex Bias in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis The net effect is that the female immune system runs hotter against myelin targets, which is advantageous for fighting infections but costly when self-tolerance breaks down.
The X Chromosome as a Risk Multiplier
Women carry two X chromosomes, and while one is supposed to be silenced early in development to equalize gene expression between the sexes, the silencing is imperfect. Some genes escape this inactivation process and end up expressed from both copies. Many of these escapee genes are immune-related, and their double dose may push the female immune system toward a more reactive state.4PubMed Central. Escape from X chromosome inactivation and female bias of autoimmune diseases This phenomenon is thought to contribute not just to MS but to the female predominance seen across autoimmune diseases generally, from lupus to rheumatoid arthritis.
Recent work on epigenetic regulation adds another layer. Small RNA molecules called microRNAs, some encoded on the X chromosome, appear to function as molecular bridges between genetic susceptibility, hormone levels, and the inflammatory cascades that damage myelin.5PubMed. Exploring Sex-Based Mechanisms of Inflammation and Neurodegeneration in Multiple Sclerosis Certain microRNA variants are associated with more severe MS specifically in women. For instance, carrying particular versions of the MIR499A gene, alone or in combination with a variant of MIR196A2, correlates with higher disease severity scores in female patients but not in males.6PubMed Central. Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity
Pregnancy as a Natural Experiment
The most dramatic illustration of hormones modulating MS comes from pregnancy. Relapse rates drop substantially during pregnancy and hit their lowest point in the first trimester, with reductions on the order of 60 to 75 percent compared to the year before conception.7JAMA Network Open. Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability This decline is attributed to the high estrogen and progesterone environment of pregnancy shifting the immune system away from the inflammatory Th1 response and toward a Th2 profile that is more tolerant of foreign tissue (the fetus) and, incidentally, less aggressive toward myelin.
The tradeoff comes after delivery. A meta-analysis of cohort studies found that the relapse rate in the first three months postpartum nearly doubles compared to preconception levels.8PubMed. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis The landmark trial that first documented this pattern, published in the late 1990s, showed relapse rates climbing sharply postpartum before returning to baseline.9PubMed. Rate of pregnancy-related relapse in multiple sclerosis This rebound is widely believed to result from the abrupt withdrawal of pregnancy hormones, combined with the immune reconstitution that occurs when the tolerogenic state of pregnancy ends. Modern disease-modifying therapies and careful planning around treatment resumption after delivery have made this postpartum window more manageable, but it remains a period that neurologists flag for close monitoring.
Puberty Timing and Childhood Obesity
Earlier puberty correlates with higher MS risk. A Mendelian randomization study estimated that each additional year of delay in puberty reduces the odds of MS by about 8 percent.10PubMed Central. Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study A separate meta-analysis of observational studies on age at menarche found a similar figure: each one-year delay in first menstruation was associated with roughly 8 percent lower MS risk.11PubMed Central. Does Age at Menarche Differ Between Patients With Multiple Sclerosis and Healthy Controls?: An Updated Systematic Review and Meta-Analysis The consistency across study designs is notable, but there is an important catch: in the Mendelian randomization analysis, the association weakened and lost significance once adult body mass index was accounted for. In other words, the link between early puberty and MS may be largely a proxy for the link between childhood obesity and MS.10PubMed Central. Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study
The obesity connection is especially stark in girls. A study of pediatric MS cases found that obesity was significantly associated with increased risk in girls but not in boys. Girls classified as extremely obese had nearly four times the odds of developing MS compared to girls at a normal weight.12PubMed Central. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome A large Danish cohort study confirmed this: among girls aged seven to thirteen, each standard-deviation increase in BMI raised MS risk by about 20 percent, and girls above the 95th percentile for BMI faced roughly 1.6 to 1.9 times the risk of girls below the 85th percentile.13PubMed Central. Childhood body mass index and multiple sclerosis risk: a long-term cohort study Fat tissue is metabolically active and produces pro-inflammatory molecules, and in girls it also contributes to earlier puberty, creating a feedback loop that may amplify immune dysregulation during a critical developmental window.
Epstein-Barr Virus and the Female Immune Response
Epstein-Barr virus (EBV) infection is now considered a near-prerequisite for MS. Nearly all MS patients show evidence of prior EBV infection, and the risk of MS in people who have never been infected is extremely low. What makes EBV particularly relevant to the female predominance is that women appear more susceptible to symptomatic EBV infections like infectious mononucleosis. One Danish study of nearly 2,500 patients found that the cumulative risk of developing symptomatic mononucleosis by age 30 was about 22 percent for women compared to 13 percent for men.14Experimental & Molecular Medicine. Epstein–Barr virus and multiple sclerosis: lesson learned to develop better nonhuman primate models
The underlying biology is informative. Women tend to have higher numbers of CD4+ T cells relative to CD8+ T cells. CD8+ T cells are the immune system’s main weapon for controlling viral infections like EBV, so having relatively fewer of them may impair viral clearance. The result may be a more persistent or poorly controlled EBV infection, which in turn creates a larger window for the molecular mimicry or bystander activation processes through which EBV is believed to trigger MS.14Experimental & Molecular Medicine. Epstein–Barr virus and multiple sclerosis: lesson learned to develop better nonhuman primate models Researchers have also noted that EBV is more widespread among female MS patients than male MS patients.15PubMed Central. Epstein-Barr Virus (EBV) and Multiple Sclerosis Disease: A Biomedical Diagnosis
Genetic Risk Alleles That Hit Harder in Women
The strongest single genetic risk factor for MS is the HLA-DRB1*1501 allele, which encodes a protein involved in presenting fragments of proteins to the immune system. But this allele does not confer equal risk across the sexes. One study found that the association between HLA-DRB1*1501 and relapsing-remitting MS was more marked in women.16PubMed. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis A study in Japanese patients went further, identifying a synergistic interaction between HLA-DRB1*1501 and a variant in the estrogen receptor gene that was specific to women. The combined effect was striking: female patients carrying both risk alleles had an odds ratio of 16 for developing MS compared to those with neither.17PubMed. Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation
This kind of gene-by-sex interaction is a recurring theme. The genetic architecture of MS is not simply a list of risk alleles with fixed effects. Many of these alleles interact with sex hormones, X-linked genes, or female-specific environmental exposures to produce risk profiles that differ meaningfully between men and women. The estrogen receptor gene interaction is one of the clearest examples, but similar patterns are emerging across the genome.
Vitamin D, Smoking, and Environmental Exposures
Low vitamin D is one of the most established environmental risk factors for MS generally, but the data suggest it may be especially relevant for women. Among women with higher dietary vitamin D intake (around 700 IU per day), MS incidence was about a third lower, and women who took vitamin D supplements of 400 IU or more per day had a 41 percent reduction in risk compared to non-users.18PubMed Central. Vitamin D and Multiple Sclerosis: A Comprehensive Review The protective effect of vitamin D and ultraviolet light exposure appears to be stronger in women than in men, although the precise reasons remain an active area of investigation.
Smoking also appears to hit women harder. Research into sex-related differences in lifestyle factors has found that women may be more vulnerable to the pro-inflammatory effects of smoking on MS risk, both on its own and when combined with genetic risk alleles like HLA-DRB1*1501.19PubMed Central. Sex-Related Differences in Lifestyle Factors Affecting Multiple Sclerosis Susceptibility and Disease Progression The interaction between smoking and genetic susceptibility is another instance of the amplification pattern: neither the gene nor the behavior alone fully explains the risk, but together they produce an outsized effect, particularly in women.
The Gut Microbiome and Estrogen Metabolism
An emerging line of research connects the gut microbiome to MS risk through estrogen metabolism. People with relapsing-remitting MS have lower levels of several bacterial groups, including Prevotella, Parabacteroides, and Adlercreutzia, all of which are involved in breaking down plant-derived estrogen-like compounds called phytoestrogens. The metabolites produced from phytoestrogen breakdown help maintain anti-inflammatory conditions at mucosal surfaces.20Scientific Reports. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
The potential connection to sex-specific risk is suggestive. Low-estrogen states in women, such as the postpartum period and menopause, are already associated with increased MS activity. If the gut microbiome of MS patients is additionally depleted of the bacteria that produce estrogen-receptor-activating metabolites, the combined effect could be a particularly unfavorable hormonal environment for women with the disease. This is still a developing area, and the causal direction is not firmly established, but it offers a plausible mechanism linking the microbiome, hormones, and the female MS bias.
What Happens at Menopause
Given how much estrogen influences MS biology, you might expect menopause to be a clear turning point. The picture is more complicated than that. A 2025 study in JAMA Neurology found that menopause itself did not significantly alter the risk of confirmed disability progression or transition to secondary progressive MS after adjusting for confounders like disease duration and baseline disability level.21JAMA Neurology. Menopause Impact on Multiple Sclerosis Disability Progression Disease duration, not menopausal status, was the main driver of worsening disability trajectory in that analysis.
However, a separate study using different outcome measures did find menopause associated with an inflection point. Functional performance worsened faster after menopause, and levels of a blood biomarker of nerve-fiber damage (neurofilament light chain) increased more steeply after the final menstrual period.22PubMed Central. Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis The discrepancy between studies may come down to which tools are used to measure decline: standard disability scales may not be sensitive enough to capture the subtle functional changes that biomarkers and performance tests detect. The honest read is that menopause probably does matter, but disentangling its effects from the simple progression of aging and disease duration remains tricky.
Night Shift Work and Circadian Disruption
An intriguing finding from the Nurses’ Health Studies, two large cohorts of American women, hints at a potential role for circadian disruption. In the main analyses, rotating night shift work was not significantly associated with MS risk at typical durations. But when researchers looked specifically at nurses with more than 20 years of rotating night shifts and used the strictest definition of MS diagnosis, they found a roughly 2.6-fold increase in risk, though this was based on a small number of cases.23PubMed Central. Rotating night shift work and risk of multiple sclerosis in the Nurses’ Health Studies The finding is provocative but should be treated cautiously: the trend test was not significant, and the estimate came from very few cases. Still, given the known connections between circadian rhythms, melatonin, vitamin D metabolism, and immune regulation, the possibility that decades of disrupted sleep-wake cycles could contribute to MS risk in women is biologically plausible and worth tracking as more data accumulate.
Early-Life Exposures and Autoimmune Clustering
Risk factors for MS in women may begin accumulating even before birth. A study of pediatric MS found that maternal illness during pregnancy was associated with about a 2.3-fold increase in the child’s odds of developing MS. Household pesticide exposure also raised risk.24American Academy of Pediatrics (Pediatrics). Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis These findings point to environmental programming during critical developmental windows, a period when immune tolerance is being established and could be disrupted.
Women with MS are also more likely to have family histories rich in other autoimmune diseases, including thyroid disease and lupus. Familial clustering of MS with conditions like Graves’ disease and systemic lupus erythematosus has been documented across multiple generations, consistent with shared genetic susceptibility to immune dysregulation.25PubMed. Familial occurrence of multiple sclerosis with thyroid disease and systemic lupus erythematosus Since all of these conditions are themselves female-predominant, the clustering reinforces the idea that the biological factors predisposing women to autoimmunity are not MS-specific. They are broad vulnerabilities in immune regulation that different triggers can push toward different diseases, and MS happens to be one of the more common destinations.
Psychological Stress and Immune Activation
Stress has long been suspected as a trigger for MS relapses, though proving causation is difficult. The proposed mechanism runs through the hypothalamic-pituitary-adrenal (HPA) axis, the body’s central stress-response system. Chronic psychological stress activates the HPA axis, which in turn alters the function of natural killer T cells and other immune populations in ways that may promote disease activity. While the HPA axis operates in both sexes, women tend to show different cortisol response patterns to chronic stress than men, and the interaction between stress hormones and sex hormones adds another dimension to how stress may differentially affect MS in women. This area remains more mechanistic hypothesis than settled science, but it is worth noting because stress is a modifiable factor, and women with MS consistently report relapse timing that correlates with periods of high emotional burden.